期刊
DISEASE MODELS & MECHANISMS
卷 14, 期 9, 页码 -出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.049078
关键词
CRISPR; Cancer; Chromosomal rearrangements; Fusion oncogenes
资金
- Memorial Sloan Kettering [T32-CA009512]
The advancements and innovations in technology have made it easier and more accurate to model cancer-associated chromosomal rearrangements in the laboratory, aiding in a better understanding of the mechanisms that regulate cancer growth.
The identification of large chromosomal rearrangements in cancers has multiplied exponentially over the last decade. These complex and often rare genomic events have traditionally been challenging to study, in part owing to lack of tools that efficiently engineer disease-associated inversions, deletions and translocations in model systems. The emergence and refinement of genome editing technologies, such as CRISPR, have significantly expanded our ability to generate and interrogate chromosomal aberrations to better understand the networks that govern cancer growth. Here we review how existing technologies are employed to faithfully model cancer-associated chromosome rearrangements in the laboratory, with the ultimate goal of developing more accurate pre-clinical models of and therapeutic strategies for cancers driven by these genomic events.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据